期刊文献+

肝硬化患者消化道状态与血氨的关系研究 被引量:17

The relationship of gastrointestinal state and plasma ammonia in cirrhosis patients
下载PDF
导出
摘要 目的研究肝硬化伴消化道功能障碍患者酸化肠道治疗前、后的血氨水平变化,探讨肝硬化患者消化道状态与血氨水平的关系,寻找减少肠道氨吸收的有效方法,达到降低血氨的目的。方法测定195例肝硬化患者(包括单纯性肝硬化患者100例、肝硬化伴消化道出血患者52例、肝硬化伴便秘患者43例)、50例单纯性肠梗阻患者、113例单纯性消化道出血患者及80名正常对照者的空腹血氨水平。比较各组血氨水平,研究肝硬化伴消化道出血或(和)便秘患者酸化肠道治疗前、后的血氨水平变化。结果肝硬化伴消化道出血组血氨水平为(67.71±30.31)μmol/L,高于单纯性肝硬化组[(45.81±28.78)μmol/L]、单纯性消化道出血组[(24.85±10.79)μmol/L]和正常对照组[(22.42±7.93)μmol/L](P<0.05)。肝硬化伴便秘组血氨水平为(95.53±42.61)μmol/L,高于单纯性肝硬化组、肝硬化伴消化道出血组和单纯性肠梗阻组[(24.90±11.02)μmol/L](P<0.05)。单纯性肝硬化组血氨水平高于单纯性消化道出血、单纯性肠梗阻组及正常对照组(P<0.05);而单纯性消化道出血、单纯性肠梗阻组与正常对照组比较差异无统计学意义(P>0.05)。肝硬化伴消化道出血或(和)便秘组治疗前血氨水平为(83.28±37.93)μmol/L,明显高于经酸化肠道治疗后的血氨水平[(50.89±19.58)μmol/L](P<0.05)。结论肝硬化患者消化道状态与血氨水平关系密切;阻止消化道出血、酸化肠道及使用抗生素可抑制肠道中氨的产生和吸收,从而降低血氨水平,预防和治疗肝性脑病。 Objective To study the changes on plasma ammonia among cirrhosis patients who had gastrointestinal symptoms before and after acidification intestinal treatment,investigate the relationship of gastrointestinal state and plasma ammonia among cirrhosis patients,and find an effective method to reduce plasma ammonia.Methods The fast plasma ammonia levels were detected among 195 cirrhosis patients(including 100 patients with just cirrhosis,52 cirrhosis patients with gastrointestinal hemorrhage and 43 cirrhosis patients with constipation),50 patients with just intestinal obstruction,113 patients with just gastrointestinal hemorrhage and 80 healthy subjects.The plasma ammonia levels were compared,and the changes on plasma ammonia levels before and after acidification intestinal treatment were analyzed in cirrhosis patients with gastrointestinal hemorrhage and(or) constipation.Results Plasma ammonia level among cirrhosis patients with gastrointestinal hemorrhage was(67.71±30.31) μmol/L,which was higher than those of patients with just cirrhosis [(45.81±28.78) μmol/L],patients with just gastrointestinal hemorrhage [(24.85±10.79) μmol/L] and the healthy controls [(22.42±7.93) μmol/L](P〈0.05).The plasma ammonia level of cirrhosis patients with constipation was(95.53±42.61) μmol/L,which was higher than those of patients with just cirrhosis,cirrhosis patients with gastrointestinal hemorrhage and patients with just intestinal obstruction [(24.90±11.02) μmol/L](P〈0.05).The plasma ammonia level of patients with just cirrhosis were higher than those of patients with just gastrointestinal hemorrhage,patients with just intestinal obstruction and healthy subjects(P〈0.05),while the plasma ammonia levels among patients with just intestinal gastrointestinal hemorrhage,patients with just obstruction and the healthy subjects showed no significant difference(P〉0.05).The plasma ammonia levels of cirrhosis patients with gastrointestinal hemorrhage and(or) constipation be
出处 《检验医学》 CAS 2012年第1期44-47,共4页 Laboratory Medicine
关键词 血氨 肝硬化 消化道出血 便秘 Plasma ammonia Cirrhosis Gastrointestinal hemorrhage Constipation
  • 相关文献

参考文献9

  • 1Ott P, Larsen FS. Blood-brain barrier permeability to ammonia in liver failure: a critical reappraisal [ J ]. Neurochem Int,2004,44(4) : 185-198. 被引量:1
  • 2Jalan R, Bernuau J. Induction of cerebral hyperemia by ammonia plus endotoxin: does hyperammonemia unlock the blood-brain barrier[J]. J Hepatol,2007,47 (2) :168-171. 被引量:1
  • 3Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1512
  • 4中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊断标准[J].中华肝脏病杂志,2003,11(2):72-72. 被引量:585
  • 5Ong JP, Aggarwal A, Krieger D, et al. Correlation between ammonia levels and the severity of hepatic encephalopathy [ J ]. Am J Med, 2003,114 ( 3 ) : 188- 193. 被引量:1
  • 6Nicolao F,Efrati C,MasiniA, et al. Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy [ J ]. J Hepatol, 2003,38 (4):441-446. 被引量:1
  • 7Bhatia V, Singh R, Acharya SK. Predictive value of arterial ammonia for complications and outcome in acute liver failure [ J ]. Gut, 2006,55 ( 1 ) : 98-104. 被引量:1
  • 8Srivastava N, Singh N, Joshi YK. Nutrition in the management of hepatic encephalopathy [ J ]. Trop Gastroenterol, 2003,24 (2) :59-62. 被引量:1
  • 9Gheorghe L, Iacob R, Vadan R, et al. Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet [ J]. Rom J Gastroenterol, 2005,14 (3) :231-238. 被引量:1

二级参考文献18

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649. 被引量:1
  • 3Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219. 被引量:1
  • 4Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231. 被引量:1
  • 5Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397. 被引量:1
  • 6Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490. 被引量:1
  • 7Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44. 被引量:1
  • 8Agrawal S,Bonkovsky HL.Management of nonalcoholic steatohepatitis:an analytic review.J Clin Gastroenterol,2002,35:253-261. 被引量:1
  • 9Comar KM,Sterling RK.Drug therapy for non-alcoholic fatty liver disease.Aliment Pharmacal Ther,2006,23:207-215. 被引量:1
  • 10Lok AS,McMahon B J; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861. 被引量:1

共引文献2087

同被引文献148

引证文献17

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部